AIM: To investigate the role that the hedgehog (Hh) signaling pathway, which includes sonic hedgehog (Shh), Patched (Ptc), Smoothened (Smo) and Gli-1, plays in human gastrointestinal stromal tumors (GISTs). METHODS: Surgically resected specimens from patients with GISTs, leiomyomas and schwannomas were examined by immunohistochemical staining for aberrant expression of hedgehog signaling components, Shh, Ptc, Smo and Gli-1, respectively. RESULTS: In GISTs, 58.1% (18 of 31), 77.4% (24 of 31), 80.6% (25 of 31) and 58.1% (18 of 31) of the specimens stained positive for Shh, Ptc, Smo and Gli-1, respectively. In leiomyomas, 92.3% (12 of 13), 92.3% (12 of 13), 69.2% (9 of 13) and 92.3% (12 of 13) stained positive for Shh, Ptc, Smo and Gli-1, respectively. In schwannomas, 83.3% (5 of 6), 83.3% (5 of 6), 83.3% (5 of 6) and 100% (6 of 6) stained positive for Shh, Ptc, Smo and Gli-1, respectively. Immunohistochemistry revealed that the expressions of Shh and Gli-1 were significantly higher in leiomyomas than in GISTs (P < 0.05, respectively). Shh expression strongly correlated with the grade of tumor risk category and with tumor size (P < 0.05, respectively). However, the expressions of Ptc and Smo did not correlate with histopathological differentiation. CONCLUSION: These results suggest that the Hh signaling pathway may play an important role in myogenic differentiation and the malignant potential of human intestinal stromal tumors.
AIM: To investigate the role that the hedgehog (Hh) signaling pathway, which includes sonic hedgehog (Shh), Patched (Ptc), Smoothened (Smo) and Gli-1, plays in humangastrointestinal stromal tumors (GISTs). METHODS: Surgically resected specimens from patients with GISTs, leiomyomas and schwannomas were examined by immunohistochemical staining for aberrant expression of hedgehog signaling components, Shh, Ptc, Smo and Gli-1, respectively. RESULTS: In GISTs, 58.1% (18 of 31), 77.4% (24 of 31), 80.6% (25 of 31) and 58.1% (18 of 31) of the specimens stained positive for Shh, Ptc, Smo and Gli-1, respectively. In leiomyomas, 92.3% (12 of 13), 92.3% (12 of 13), 69.2% (9 of 13) and 92.3% (12 of 13) stained positive for Shh, Ptc, Smo and Gli-1, respectively. In schwannomas, 83.3% (5 of 6), 83.3% (5 of 6), 83.3% (5 of 6) and 100% (6 of 6) stained positive for Shh, Ptc, Smo and Gli-1, respectively. Immunohistochemistry revealed that the expressions of Shh and Gli-1 were significantly higher in leiomyomas than in GISTs (P < 0.05, respectively). Shh expression strongly correlated with the grade of tumor risk category and with tumor size (P < 0.05, respectively). However, the expressions of Ptc and Smo did not correlate with histopathological differentiation. CONCLUSION: These results suggest that the Hh signaling pathway may play an important role in myogenic differentiation and the malignant potential of humanintestinal stromal tumors.
Authors: H Joensuu; P J Roberts; M Sarlomo-Rikala; L C Andersson; P Tervahartiala; D Tuveson; S Silberman; R Capdeville; S Dimitrijevic; B Druker; G D Demetri Journal: N Engl J Med Date: 2001-04-05 Impact factor: 91.245
Authors: G R van den Brink; J C H Hardwick; C Nielsen; C Xu; F J ten Kate; J Glickman; S J H van Deventer; D J Roberts; M P Peppelenbosch Journal: Gut Date: 2002-11 Impact factor: 23.059
Authors: Marilyn L Lamm; Winnie S Catbagan; Robert J Laciak; Daniel H Barnett; Christy M Hebner; William Gaffield; David Walterhouse; Philip Iannaccone; Wade Bushman Journal: Dev Biol Date: 2002-09-15 Impact factor: 3.582
Authors: Felicite K Noubissi; Srikanta Goswami; Nicholas A Sanek; Kazuyuki Kawakami; Toshinari Minamoto; Amy Moser; Yevgenya Grinblat; Vladimir S Spiegelman Journal: Cancer Res Date: 2009-11-03 Impact factor: 12.701
Authors: Penelope Pelczar; Arne Zibat; Willemijn A van Dop; Jarom Heijmans; Annalen Bleckmann; Wolfgang Gruber; Frauke Nitzki; Anja Uhmann; Maria V Guijarro; Eva Hernando; Kai Dittmann; Jürgen Wienands; Ralf Dressel; Leszek Wojnowski; Claudia Binder; Takahiro Taguchi; Tim Beissbarth; Pancras C W Hogendoorn; Cristina R Antonescu; Brian P Rubin; Walter Schulz-Schaeffer; Fritz Aberger; Gijs R van den Brink; Heidi Hahn Journal: Gastroenterology Date: 2012-10-03 Impact factor: 22.682
Authors: Chad M McKee; Danmei Xu; Yunhong Cao; Sheheryar Kabraji; Danny Allen; Veerle Kersemans; John Beech; Sean Smart; Freddie Hamdy; Adrian Ishkanian; Jenna Sykes; Melania Pintile; Michael Milosevic; Theodorus van der Kwast; Gaetano Zafarana; Varune Rohan Ramnarine; Igor Jurisica; Chad Mallof; Wan Lam; Robert G Bristow; Ruth J Muschel Journal: J Clin Invest Date: 2012-10-08 Impact factor: 14.808
Authors: Peng Du; Hai-Rong Ye; Jun Gao; Wei Chen; Zhong-Chuan Wang; Hong-Hua Jiang; Ji Xu; Ji-We Zhang; Jian-Cheng Zhang; Long Cui Journal: World J Gastroenterol Date: 2009-08-14 Impact factor: 5.742
Authors: Annelies Gonnissen; Sofie Isebaert; Christiaan Perneel; Chad M McKee; Filip Van Utterbeeck; Evelyne Lerut; Clare Verrill; Richard J Bryant; Steven Joniau; Ruth J Muschel; Karin Haustermans Journal: Am J Pathol Date: 2018-01-12 Impact factor: 4.307